🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

4+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 4 of 4 recruiting trials for “lipoprotein-glomerulopathy”

RecruitingNCT07156149 ↗

Fabhalta Capsules Specified Drug-use Survey

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 23 sites📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT07483827 ↗

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

👨‍⚕️ Bernd Jilma, Prof., Medical University of Vienna📍 16 sites📅 Started Jun 2025View details ↗
RecruitingNCT07029542 ↗

Home Reported Outcomes in C3G Study

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 1 site📅 Started Apr 2025View details ↗
Phase 3RecruitingNCT04817618 ↗

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 87 sites📅 Started Jul 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →